North Star Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
North Star Asset Management's GILD Position: Q2 2026 in Review
North Star Asset Management reduced its Gilead Sciences (GILD) stake by 9.6% in Q2 2026, selling an estimated $27.5K and leaving 1,978 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #329.
North Star Asset Management first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $377K in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- North Star Asset Management held 1,978 shares of Gilead Sciences worth $250K as of Q2 2026.
- North Star Asset Management sold 209 Gilead Sciences shares in Q2 2026, an estimated $27.5K.
- Gilead Sciences made up 0.01% of North Star Asset Management's portfolio in Q2 2026, its #329 holding.
- North Star Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
- North Star Asset Management's Gilead Sciences position peaked at $377K in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.